52

Pharmaids Pharmaceuticals LtdBOM 524572 Stock Report

Last reporting period 30 Sep, 2023

Updated 20 Sep, 2024

Last price

Market cap $B

0

Micro

Exchange

XBOM - Bombay Stock Exchange

524572.BO Stock Analysis

52

Uncovered

Pharmaids Pharmaceuticals Ltd is uncovered by Eyestock quantitative analysis.

Market cap $B

0

Dividend yield

Shares outstanding

35.27 B

Pharmaids Pharmaceuticals Ltd. engages in the development, formulation, manufacture, and distribution of drugs. The company is headquartered in Hyderabad, Karnataka. The firm is engaged in the business of trading and manufacturing of generics, bulk drugs and intermediaries, and other. The firm operates through a single segment, Drug Formulations. Its specialty chemicals products include Retino!, DL Alpha Tocopherol, D Pantothenate, Cyanocobalamin, Pyridoxine Hcl, Thiamine, Nicotinic Acid, Water Sol. Vitamin E, Coenzyme Q10 and D-Biotin. Its skin care products include Best care hands, Hands Sanitizer, Moisturizing Cream, Skinsure Plus, SkinSure Ultra, Alcohol Gel and Barrier Cream. Its hospital care products include Xepi Rub M, Facein Spray, Sod Hypochlorite, Sanmedin, Strumen G, Strumen TRIACID, Facein Eco, Facein Power 256, Facein Spray, Sod Hypochlorite, Wipes and PPE. Its generic products include Linzomust, Benfoshine, Amplimmune and other.

View Section: Eyestock Rating